Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Other financing activities (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Other financing activities for 16 consecutive years, with -$26000.0 as the latest value for Q1 2026.

  • For Q1 2026, Other financing activities fell 100.14% year-over-year to -$26000.0; the TTM value through Mar 2026 reached -$10.0 million, down 153.73%, while the annual FY2025 figure was $8.6 million, 469.1% up from the prior year.
  • Other financing activities hit -$26000.0 in Q1 2026 for Acadia Healthcare Company, up from -$10.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $18.7 million in Q3 2025 and bottomed at -$18.7 million in Q2 2025.
  • Average Other financing activities over 5 years is $1.6 million, with a median of $733000.0 recorded in 2022.
  • Year-over-year, Other financing activities soared 11721.43% in 2023 and then tumbled 1386.85% in 2025.
  • Acadia Healthcare Company's Other financing activities stood at $15.3 million in 2022, then plummeted by 116.32% to -$2.5 million in 2023, then skyrocketed by 41.94% to -$1.5 million in 2024, then plummeted by 587.05% to -$10.0 million in 2025, then skyrocketed by 99.74% to -$26000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods came in at -$26000.0, -$10.0 million, and $18.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.